Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile
Muscular Dystrophy News Today

@mdnewstoday_

We are dedicated to sharing the latest news, research, and muscular dystrophy patient perspectives.

ID: 1125767064101236736

linkhttp://musculardystrophynews.com calendar_today07-05-2019 14:19:18

2,2K Tweet

1,1K Takipçi

28 Takip Edilen

Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

The approval allows the DMD gene therapy to be sold in Japan for up to seven years, but more trials will be needed for full approval. bit.ly/3FeD2mt #MuscularDystrophyNews #MuscularDystrophy

The approval allows the DMD gene therapy to be sold in Japan for up to seven years, but more trials will be needed for full approval. bit.ly/3FeD2mt 

#MuscularDystrophyNews #MuscularDystrophy
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

New data demonstrated the benefits of Elevidys, a gene therapy for multiple Duchenne muscular dystrophy, in different age groups. bit.ly/4jaoQso #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

New data demonstrated the benefits of Elevidys, a gene therapy for multiple Duchenne muscular dystrophy, in different age groups. bit.ly/4jaoQso

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

There isn’t a road map to navigate raising a child with DMD, but words of wisdom from others who have faced a similar journey may help. bit.ly/43eBbpy #duchennemusculardystrophy #DMD #caregiver

There isn’t a road map to navigate raising a child with DMD, but words of wisdom from others who have faced a similar journey may help. bit.ly/43eBbpy 

#duchennemusculardystrophy #DMD #caregiver
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Columnist Shalom Lim stood up for his right to inclusive access to a major sporting event — and a local soccer club responded. bit.ly/43nqrFx #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

Columnist Shalom Lim stood up for his right to inclusive access to a major sporting event — and a local soccer club responded. bit.ly/43nqrFx

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Aging with FSHD brings many challenges, columnist Robin Stemple says, but he works hard to maintain an attitude of gratitude. bit.ly/3HkwNOs #MuscularDystrophyNews #MuscularDystrophy

Aging with FSHD brings many challenges, columnist Robin Stemple says, but he works hard to maintain an attitude of gratitude. bit.ly/3HkwNOs 

#MuscularDystrophyNews #MuscularDystrophy
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Exon-skipping therapies work by removing certain exons in the DMD gene sequence to create a better fit with remaining exons. Learn more here: bit.ly/43iGF2F #MuscularDystrophy #MDCommunity #LivingWithMD

Exon-skipping therapies work by removing certain exons in the DMD gene sequence to create a better fit with remaining exons. Learn more here: bit.ly/43iGF2F 

#MuscularDystrophy #MDCommunity #LivingWithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Long-term data from Genethon’s GNT0004 Phase 1/2 trial reveal sustained motor function in boys with Duchenne muscular dystrophy. buff.ly/irXQpLq #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

Long-term data from Genethon’s GNT0004 Phase 1/2 trial reveal sustained motor function in boys with Duchenne muscular dystrophy. buff.ly/irXQpLq

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

A couple of speeches recently helped columnist Betty Vertin newly appreciate how much motherhood has been her life purpose. buff.ly/Gndm3hR #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

A couple of speeches recently helped columnist Betty Vertin newly appreciate how much motherhood has been her life purpose. buff.ly/Gndm3hR

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Here is this week's most-read article featured on our website. Are you caught up? buff.ly/Xxa7qPR #MuscularDystrophyNews #MuscularDystrophy

Here is this week's most-read article featured on our website. Are you caught up? buff.ly/Xxa7qPR 

#MuscularDystrophyNews #MuscularDystrophy
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Long-term data from Genethon’s GNT0004 Phase 1/2 trial reveal sustained motor function in boys with Duchenne muscular dystrophy. buff.ly/O7gvVfx #MuscularDystrophyNews #MuscularDystrophy

Long-term data from Genethon’s GNT0004 Phase 1/2 trial reveal sustained motor function in boys with Duchenne muscular dystrophy. buff.ly/O7gvVfx 

#MuscularDystrophyNews #MuscularDystrophy
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

DMD treatment SAT-3247 was safe and well-tolerated, and showed signs of increasing muscle strength in five adults, Satellos said. buff.ly/dFXzBMA #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

DMD treatment SAT-3247 was safe and well-tolerated, and showed signs of increasing muscle strength in five adults, Satellos said. buff.ly/dFXzBMA

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

A couple of speeches recently helped columnist Betty Vertin newly appreciate how much motherhood has been her life purpose. buff.ly/hgRhFny #MuscularDystrophyNews #MuscularDystrophy

A couple of speeches recently helped columnist Betty Vertin newly appreciate how much motherhood has been her life purpose. buff.ly/hgRhFny 

#MuscularDystrophyNews #MuscularDystrophy
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

CureDuchenne is investing $1 million in Entos Pharmaceuticals to support the development of a new DMD gene therapy. buff.ly/ZsD9NPM #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

CureDuchenne is investing $1 million in Entos Pharmaceuticals to support the development of a new DMD gene therapy. buff.ly/ZsD9NPM

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

After taking a day for reflection on her sons' lives with DMD, columnist Betty Vertin says she feels more on top of their care. buff.ly/mpd4QBp #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

After taking a day for reflection on her sons' lives with DMD, columnist Betty Vertin says she feels more on top of their care. buff.ly/mpd4QBp

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Here is this week's most-read article featured on our website. Are you caught up? buff.ly/8YTRcud #MuscularDystrophyNews #MuscularDystrophy

Here is this week's most-read article featured on our website. Are you caught up? buff.ly/8YTRcud 

#MuscularDystrophyNews #MuscularDystrophy
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

With FSHD, the need to adapt seems never-ending, which is why columnist Robin Stemple and others feel like they're constantly in transition. buff.ly/JhQ6ZcP #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

With FSHD, the need to adapt seems never-ending, which is why columnist Robin Stemple and others feel like they're constantly in transition. buff.ly/JhQ6ZcP

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Pepgen will stop development of its Duchenne MD exon-skipping therapy PGN-ED051 after increases in dystrophin levels proved disappointing. buff.ly/usQtqRt #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

Pepgen will stop development of its Duchenne MD exon-skipping therapy PGN-ED051 after increases in dystrophin levels proved disappointing. buff.ly/usQtqRt

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Building empathy and having clear communication are key to improving patient outcomes in DMD, writes columnist Shalom Lim. buff.ly/oduG72f #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

Building empathy and having clear communication are key to improving patient outcomes in DMD, writes columnist Shalom Lim. buff.ly/oduG72f

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

The FDA has awarded orphan drug status to ISX9-CPC, an experimental stem cell therapy targeting heart problems in Duchenne muscular dystrophy. buff.ly/NnEvJTg #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

The FDA has awarded orphan drug status to ISX9-CPC, an experimental stem cell therapy targeting heart problems in Duchenne muscular dystrophy. buff.ly/NnEvJTg

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD
Muscular Dystrophy News Today (@mdnewstoday_) 's Twitter Profile Photo

Columnist Betty Vertin acknowledges the mixed feelings of fear and pride as her youngest son with DMD begins with high school band. buff.ly/2r3sFcF #musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

Columnist Betty Vertin acknowledges the mixed feelings of fear and pride as her youngest son with DMD begins with high school band. buff.ly/2r3sFcF

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD